These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20933567)

  • 1. Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs.
    Toledo JR; Barrera M; Farnós O; Gómez S; Rodríguez MP; Aguero F; Ormazabal V; Parra NC; Suárez L; Sánchez O
    Vaccine; 2010 Nov; 28(50):7907-14. PubMed ID: 20933567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
    Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
    Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of the novel chimeric subunit vaccine E2-CD154 confers early full protection against classical swine fever virus.
    Suárez M; Sordo Y; Prieto Y; Rodríguez MP; Méndez L; Rodríguez EM; Rodríguez-Mallon A; Lorenzo E; Santana E; González N; Naranjo P; Frías MT; Carpio Y; Estrada MP
    Vaccine; 2017 Aug; 35(34):4437-4443. PubMed ID: 28688785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
    Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
    Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats.
    Toledo JR; Sánchez O; Montesino R; Farnos O; Rodríguez MP; Alfonso P; Oramas N; Rodríguez E; Santana E; Vega E; Ganges L; Frias MT; Cremata J; Barrera M
    J Biotechnol; 2008 Feb; 133(3):370-6. PubMed ID: 18045719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
    Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
    Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
    Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-γ as immunoadjuvant in weaning piglets.
    Zhang H; Wen W; Zhao Z; Wang J; Chen H; Qian P; Li X
    Vaccine; 2018 Nov; 36(48):7353-7360. PubMed ID: 30366801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
    Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
    Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.
    Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the protective efficacy of recombinant adenoviruses against classical swine fever.
    Sun Y; Li HY; Zhang XJ; Chang TM; He F; Wang XP; Liu DF; Qiu HJ
    Immunol Lett; 2011 Mar; 135(1-2):43-9. PubMed ID: 20923683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats.
    Sánchez O; Barrera M; Farnós O; Parra NC; Salgado ER; Saavedra PA; Meza CD; Rivas CI; Cortez-San Martín M; Toledo JR
    Clin Vaccine Immunol; 2014 Dec; 21(12):1628-34. PubMed ID: 25274802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of classical swine fever control: modified live and E2 subunit vaccines.
    Huang YL; Deng MC; Wang FI; Huang CC; Chang CY
    Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.
    Dong XN; Chen YH
    Vaccine; 2006 Mar; 24(11):1906-13. PubMed ID: 16300867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
    Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
    Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.